Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohorts

15 May 2024

Abstract excerpt

Pancreatic cancer (PC) is the deadliest malignancy due to late diagnosis. Aberrant alterations in the blood proteome might serve as biomarkers to facilitate early detection of PC. We designed a nested case-control study of incident PC based on a prospective cohort of 38,295 elderly Chinese participants with ∼5.7 years' follow-up. Forty matched case-control pairs passed the quality controls for the proximity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin in disease pathology
Share to Pancreatic and Hepatic Oncology Research
Share to Pancreatitis Pathology and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38754433
DOI: 10.1016/j.xgen.2024.100561

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohortsPMID 38754433Read ↗

Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.Semantic proximity Read ↗

Exploring Potential Drug Targets for Pancreatic Cancer Based on Mendelian RandomizationSemantic proximity Read ↗

The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals.Semantic proximity Read ↗

Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic CancerSemantic proximity Read ↗

Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.Semantic proximity Read ↗

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.Semantic proximity Read ↗

Identification of PRRG1 as a possible molecular target of pancreatic cancerSemantic proximity Read ↗

Dyslipidemia in Chinese Pancreatic Cancer Patients: A Two-Center Retrospective StudySemantic proximity Read ↗

A Phenome-Wide Mendelian Randomization Study of Pancreatic Cancer Using Summary Genetic DataSemantic proximity Read ↗

Impact of Lipid-Lowering Therapy on Pancreatic Health: Insights from Mendelian RandomizationSemantic proximity Read ↗

A genetic perspective on the relationship between circulating proteins and bladder cancer: a study from drug-targeted Mendelian randomizationSemantic proximity Read ↗

Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.